| Patients with a negative blood smear receiving antimalarial treatment (N = 136) |
129 |
94.9% |
87.8–100 |
|
Reported frequency of evaluation by health workers during hospitalization
|
|
|
|
| Once every day |
410 |
50.1 |
|
| Twice or thrice daily |
265 |
32.4 |
|
| Never seen |
102 |
12.5 |
|
|
Patients purchasing medications
|
385 |
44 |
34.8–53.9 |
| Purchased medications |
214 |
44.5 |
|
| Quinine |
76 |
15.8 |
|
| Antibiotics |
38 |
7.9 |
|
| Haematinics |
|
|
|
|
Patients purchasing medical supplies
|
478 |
70.6 |
61.7–79.5 |
| Purchased medical supplies |
223 |
33.4 |
|
| Intravenous cannula |
162 |
24.3 |
|
| Intravenous fluids |
109 |
16.3 |
|
| Syringes |
101 |
15.0 |
|
| Giving sets |
27 |
4.0 |
|
| Gloves |
|
|
|
|
Correct antimalarial treatment
|
823 |
94.8 |
91.7–98.7 |
|
Initial parenteral antimalarial medicine prescribed
|
|
|
|
| Quinine |
815 |
93.9 |
|
| Artemether |
8 |
0.9 |
51.9–87.3 |
| Initial parenteral antimalarial medicine dose and dosing regimen |
611 |
70.4 |
12.0–21.9 |
| Initial parenteral antimalarial medicine, dosing regimen and mode of administration (appropriately treated) |
147 |
16.9 |
|
|
Oral continuation therapy (n = 486)
|
429 |
88.3 |
|
| Oral quinine |
274 |
63.9 |
28.8–85.3 |
| Artemether-lumefantrine |
149 |
34.7 |
15.1–47.0 |
| Dihydroartemisinin-piperaquine |
6 |
1.4 |
0–3.4 |
